chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sweating; Body aches; chills; slight arm soreness; little fever/had low grade fever 100/102.7; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), PYREXIA (little fever/had low grade fever 100/102.7), PAIN (Body aches), CHILLS (chills) and VACCINATION SITE PAIN (slight arm soreness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029LL0A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, LEVOTHYROXINE and ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (little fever/had low grade fever 100/102.7) and VACCINATION SITE PAIN (slight arm soreness). On 22-Jan-2021, the patient experienced HYPERHIDROSIS (Sweating), PAIN (Body aches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 23-Jan-2021, HYPERHIDROSIS (Sweating), PYREXIA (little fever/had low grade fever 100/102.7), PAIN (Body aches), CHILLS (chills) and VACCINATION SITE PAIN (slight arm soreness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 100 (High) High and 102.7 (High) High. On 22-Jan-2021, COVID-19: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Bell's palsy; Other zoster-related conditions; Information has been received from lawyer regarding a case in litigation, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant therapies was not provided. On and or about 31-DEC-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot # and expiration date were not provided), as long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient was treated by healthcare providers for bell's palsy and other zoster-related conditions (ill-defined disorder). As a direct and proximate result of vaccination with zoster vaccine live (ZOSTAVAX), the patient had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages. At the time of the report, the outcome of bell's palsy and ill-defined disorder was determined to be not recovered. The reporter considered bell's palsy and ill-defined disorder to be related to Zoster Vaccine Live (ZOSTAVAX).     Upon internal review, bell's palsy was determined to be medically significant.
Mom reported via phone patient had approx. quarter sized reddend raised area at site of injection.  Child had low grade fever and has continued to be playful.  Mom states child had appointment with pediatrician for cold sypmtoms and showed area to physician at that visit.
Patient complaining of severe headache. EMS was called to scene. Patient had vitals taken, vitals within normal limits. BP 115/75. HR 92. O2 SAT 98%. Patient denies past medical history and refused transportation to hospital. Patient taken home by husband.
pt exp flu vax  630PM started aches, queazy, no vomiting, fever, chills; did not call MD-ill in bed 24OCT;back to work 25OCT-still achey w/low grade fever
It started as a scratchy throat.  That night became nasal congestion, cough, and a headache.  The next day I called the doctor to try and get on Paxlovid.  I probably had a slight fever but didn't take my temperature. I was able to do a Telehealth visit and was prescribed Paxlovid.
Purpuric rash to bilateral lower extremities developed 2 days after vaccination.  No other symptoms were present.   Patient was re-examined  at day 6 post vaccination.  Rash was resolving nicely, with no new lesions present.
Patient had 2nd covid vaccine his wife noticed in Observation room his eye was red she did not notice this prior to the vaccine. Patient was taken to urgent care for evaluation. Seen in UC, and discharged home with f/u ophthalmology in 2 weeks or sooner if worsening symptoms.
She had some allergic reaction with shrimp; had hard time breathing; throat was swollen; missed the second dose scheduled; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) reported for herself.  A female patient of unspecified age received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date 2021, after the vaccination, the patient experienced allergic reaction with shrimp, and she had hard time breathing, and the throat was swollen and she missed the second dose scheduled, which was supposed to be on 20Apr2021. And now she wanted to take the second dose and her doctor advised her to take the second dose but just safety medication of Benadryl, if in case she will take the second dose. she just needs a record, something that shows that she had the first shot, the patient misplaced the card, she cannot find it. she wants to get the second shot in the morning. but she can't, she does not have the record for the first shot. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.  Follow-up (08Sep2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Patient states head feels heavy, short term memory loss, has no concept of himself/car moving while driving, doesn't feel himself.
I listed all three COVID-19 vaccines I've had to date.  About 6 to 8 weeks after my 2nd Pfizer vaccine I began experiencing Tinnitus in both ears... No clue if the vaccines have anything to do with this but I've never had Tinnitus before and have not had an experience that would knowingly cause this condition. I was watching the news one night and there was a report about some people experiencing tinnitus, wondering if it "might be" related to COVID vaccines or COVID-19 itself. To my knowledge, I've never had COVID-19. My jaw dropped and I felt I should report this... if we don't look into possible side effects, and report ANYTHING different about our bodies before we had the vaccines, how will scientists ever know what's happening.  I did have some ear wax removed from one ear after my hearing became muffled and that helped my left ear and my hearing but the Tinnitus remains in both ears... and honestly.. after my Moderna booster on 11/9/2021... I'm noticing it's getting increasingly more intense. I plan on going to either a hearing doctor and/or ENT to get checked out further. Don't know if this is related to the vaccines or the disease but I'm all for Vaccines and would just like to know if they may have caused this condition. I can live with it but it's a mystery that did not occur until after a couple of Covid vaccines.
Breakthrough case admission after 3 vaccines Pfizer 4/30/21 Lot# Ew0172; Pfizer 5/21/21 Lot# Ew8732;  Pfizer 10/11/21 Lot# FF8841
1 referral for 18yo, NKDA, no food, latex environmental allergies, no health issues, on no medication 3/24 patient receive TWINRIX3 and first flu vaccine (SKB quad preservative free-FLUARIX). 3/25 went hiking on a wood path near ocean. She was in shorts, had 2 small dogs running in an out of bush/woods (a yorkie and a shiatzu) that may have come in contact with something - gave both baths that day. that evening noted swelling and itching of legs waxing and waning. She did not recall or see any specific insect bites. She self-treated with calamine lotion and noticed showers made rash redder and itch more. She had difficulty sleeping that night. 3/26 was feeling better, rash resolving and did not spread or worsen 3/27 presented to clinic with red hive to right temple region and the red rash was still present on both calves and anterior right shin/thigh and her lower gums were sore and swollen with white sores in mouth, and she had diffuse body pain, aches, muscle pain and fatigue (as if she were 82 yo and couldn't get out of bed). She used TYLENOL for discomfort. Denies any fever, no rash to palms/soles or anywhere else on body. No eye symptoms. EXAM: no rash Dx Irritant contact dermatitis to plants - Provider treated with ALLEGRA, hydrocortisone cream for rash. 3/31 Went to urgent care c/o tongue white and mouth sore (records not available), had normal CBC, and was given Amoxicillin and MEDROL dose pack. She again denies any fever (above 99), headaches, n/v/d or difficulty swallowing or any other symptom. 4/3 and 4/4 Seen by clinic - Feels worse today. Gums and mouth are in pain, "hard to get out of bed" due to body pains. States pain mostly to arms, legs and neck...no pain with flexion of neck, had difficulty eating but not swallowing. States roof of mouth feels swollen and fat, but again denies any SOB, not drooling, no throat tightness. Speech clear but sounds as if mouth has food in it. No current rashes on legs or face. Clinic treated with viscous lidocaine, BENADRYL, ZANTAC and had following labs drawn: ANA, CBC w/diff, CRP, ESR, Lyme, Ricketts.
NO adverse event reported; Patient has received Dose #1 on 1/4/2022 (T006849  6/16/2022) Dose # 2 on 3/11/2022 (T006849  6/16/2022) and a 3rd dose on 4/15/2022 (T020618  3/16/2023); This spontaneous report was received from a medical assistant referring to a 5-month-old female patient.  The patient's medical history, concurrent conditions and previous drug reactions or allergies were not reported. The patient's concomitant medications included rotavirus vaccine (+) live (+) oral (+) pentavalent (ROTATEQ), pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) and diphtheria vaccine toxoid (+) hepatitis b vaccine rhbsag (yeast) (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (PEDIARIX).   On 04-JAN-2022, the patient was vaccinated by a healthcare professional with the first dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 milliliter (ml), lot: number T006849, which was determined to be valid, with expiration date: 16-JUN-2022, administered intramuscularly for prophylaxis (strength and anatomical site were not provided). On 11-MAR-2022, the patient received the second dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 milliliter (ml), lot number: T006849, which was determined to be valid, with expiration date: 16-JUN-2022, administered intramuscularly for prophylaxis (strength and anatomical site were not provided). On 15-APR-2022, the patient received an unscheduled dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 milliliter (ml), lot number: T020618, which was determined to be valid, with expiration date: 16-MAR-2023, administered intramuscularly for prophylaxis (strength and anatomical site were not provided) (extra dose administered). At the time of reporting, the outcome of the event extra dose administered was recovered.   There were no other adverse event or product quality complaint reported.
Information has been received from a health professional concerning an approximately 10 year old white female who in August 1996 was vaccinated with Varivax (lot 617265/0566D). Subsequently, the patient experienced a generalized rash with < 50 lesions. It was unknown if the case was documented or evaluated by a physician. The child was not hospitalized. No additional information was provided. Additional information has been requested.
Patient experienced localized reaction to vaccine,   it was red with little dots kind of like petechiae and bruising
This case was reported by a nurse via call center representative and described the occurrence of injection site hives in a female patient who received FLUARIX QUADRIVALENT (batch number B5592, expiry date 20th June 2017). On 11th October 2016, the patient received FLUARIX QUADRIVLENT .5 ml. On 11th October 2016, less than a day after receiving FLUARIX QUADRIVLENT, the patient experienced injection site hives. The patient was treated with hydrocortisone and BENADRYL. In October 2016, the outcome of the injection site hives was recovered/resolved. It was not reported if the reporter considered the injection site hives to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced localized hives on left deltoid after receiving FLUARIX QUADRIVLENT. It had resolved 3 to 4 hours after putting hydrocortisone on the site and taking BENADRYL.
Day 10 after vaccine injection, patient had new onset severe acute gout episode in left thumb joint/ left wrist. (Same arm as vaccination injection.) Patient described gout much more likely to present when immune system is under stress, though he had never had a severe gout symptom in upper part of body before this event. Gout cleared by Day 18 after vaccination.
PATIENT REPORTED DIZZINESS "VERTIGO" 10 MINUTES POST VACCINATION PLACED. THEN COMPLAINED OF TIGHTENING SENSATION IN THROAT 3 MINUTES AFTER DIZZINESS BEGAN. ALSO REPORTED JAW TIGHTNESS WITH THROAT SENSATION. 1ST SET OF VS: 141/91, HEART RATE 87, PULSE OXIMETRY 100% ROOM AIR ZYRTEC 10 MG CHEWABLE GIVEN PO AT 9 AM. 2ND SET OF VS: 127/90 , HEART RATE 77, PULSE OXIMETRY 100% ROOM AIR REPORTED LESSENING OF THROAT TIGHTNESS AND RESOLUTON OF JAW STIFFNESS APPROXIMATELY 15 MINUTES AFTER 9 AM DOSE OF ZYRTEC ORAL MED. DOCTOR ONSITE AND ADVISED PATIENT TO NOTIFY HER PERSONAL PHYSICIAN OF TODAY'S REACTION TO THE COVID-19 VACCINE. PATIENT WITH HISTORY OF ALLERGY TO PENICILLIN, ASPIRIN, SULFA, ERYTHROMYCIN, BENADRYL (DROWSINESS). LAST SET OF VS 123/85, HR 75, PULSE OXIMETRY 98% DANGLED FEET AT BEDSIDE FOR 5 MINUTES, THEN STOOD AND TRANSFERRED TO WHEELCHAIR. PATIENT WENT VIA WHEELCHAIR WITH TRANSPORT PERSONNEL AND HUSBAND TO CAR ABOUT 9:45 AM.
Red spot on the back of her right arm where she received varicella vaccine 2 days ago. Denies any fever or other s/sx treated with ibuprofen prn and diphenhydramine prn and warm compresses.
ABOUT 10 MINUTES AFTER INJECTION, RESIDENT SLUMPED FORWARD AND BECAME UNRESPONSIVE.  PULSE WAS 90, PULSE OXIMETER READ 94, WEAK BP.  BREATHING APPEARED NORMAL AND UNLABORED. WHEN PATIENT FAILED TO RESPOND, SHE WAS SENT BY AMBULANCE TO THE HOSPITAL.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unspecified by reporter. On an unknown date unspecified number of unspecified patients vaccinated with oral, ROTATEQ (oral, dose and lot number was unkonwn) that were exposed to temperatures outside of the proper storage range (stored temperatures were unspecified by reporter). No adverse effect reported. The outcome of the events was unknown. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Patient had panic attack about 10 minutes after receiving second dose of Pfizer. She said she had a hard time breathing, was asked if she felt her throat/tongue were swelling and she stated no. Patient was directed to take a seat and take deep breaths, remain calm and drink some water. After about 10 more minutes she began hyperventilating, said she felt shaky and nauseous. She requested 911 to be called. 911 was called, patient was monitored - remained conscious and seated upright throughout, but continued to breath quickly. Paramedics arrived and took her with them.
No sense of taste; no sense of taste or smell; mild pain in her arm; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration date: was not reported), via unspecified route, administered on 03-MAR-202115:00 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that she think she was ok, but she was scared". patient asking if loss of taste and smell are side effects of the covid vaccine and was this a contraindication to getting the second dose. She received the "first Pfizer Covid shot on 03-MAR-202115:00 (Wednesday afternoon) and on 04Mar2021 (yesterday)  she had soreness in her arm, She only had some mild pain in her arm, she took Tylenol as recommended for any discomfort afterwards. But this morning on 05Mar2021 she  woke up and she have no sense of taste or smell". Her most pressing question this morning was should she go and get a COVID test; is that going to be useful because she has been administered the Pfizer COVID-19 Vaccine; what if she now has the virus which she probably had before she got the Pfizer COVID-19 Vaccine. The outcome of events was unknown.    No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained.
Death  7/25/21 N17.9 - AKI (acute kidney injury) K92.2 - Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type
Information has been received from a registered nurse concerning a 2 month old female who on 29-JUL-2008 was vaccinated orally with the first dose of ROTATEQ vaccine live (human-bovine) (lot number: 660679/0407X) and within 24 hours developed grey colored diarrhea that has persisted. The patient is reported to be recovering. Additional information has been requested. Additional information has been received from a physician indicating that the patient developed gray diarrhea within one week of receiving ROTATEQ. The diarrhea continued for one month and then went back to normal color. The patient was not previously exposed to this or related drug. Additional information is not expected.
Seizure vs sleep apneic episode 5/3/16 while napping at daycare. Seen at ED immed after.
01Oct88 pt neg for antiHBs,antiHBc,1st Hep B vax 27Jan89 2nd vax pos for antiHBs,neg for antiHBc.26Jul89 pt vax 3rd hepta B;Apr90 pt pos for antiHBs + neg for antiHBc.Subsequently,pt exp chronic fatigue + found to be antiHBs + antiHBc pos.
In December, one month after dose 4, I got sick with symptoms with COVID-19 with cough and fever.  My symptoms got worse including body aches, congestion, sore throat, headache, skin sensitivity, loss of taste and smell and fatigue beginning December 10 through 16.  I began to feel better around day 7.  I still had a low fever.  On December 27 I developed a new sore throat and congestion and by the 28th I was taking amoxicillin for a sinus infection.  On January 1st I began taking a steroid for the infection.  I developed joint pain on January 12, 2023.  My fingers were swollen and stiff.  I began to have joint pain all over my body, especially my hands and feet.  I saw my primary care doctor January 25, 2023, and lab tests and prescribed Celebrex .  I saw a hand surgeon on January 10.  I saw a rheumatologist on January 26th.  I saw a dermatologist on February 1, 2023 .  I was diagnosed with psoriasis and also psoriatic arthritis.
5 DTaP reaction; not infectious. Right upper arm, not crossing joints; several on erythema, warm, mildly tender. No focal nodes, radius pulse 2X, UE w/full strength, from.
Patient is COVID-19 + on 8/31/21. Patient was admitted for recurrent UTI but has since developed acute hypoxemic respiratory failure with possible bacterial pneumonia. The patient was transferred from medical floor to ICU and put on high flow oxygen.  Resulting in prolongation of existing hospitalization.
Diarrhea, weakness, shaky feeling on the inside of my  body, feverish on the inside of body but not hot to the touch on the out side and no temperature,  tired, lightheaded, for one day. Redness and swelling at injection site, left arm very sore and tender to the touch , hurts to move it , lift it , or lay on it in bed for three days so far. .
Pt had dizziness, sweating, vision problems the day after the flu shot was administered (09/10/09). Pt was perfectly ok on the day they called (09/15/09). Asked pt to see the doctor.
Vaccine is FDA approved for 18+ but got administered to this pt during an offsite clinic and didn't get noticed until later during data entry.
Polymyalgia rheumatica onset 08/2021. Treatment since then with prednisone (ongoing).
Mom noticed Wed afternoon that (L) deltoid was red, swollen and warm to touch - no c/o pain; (positive) itch.
2 small raised erythematous papules at injection site & mild maculo papular rash of torso / abdomen.
Second dose / on April 39th 2021 / first dose was / on March 12th 2021; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number F5XN2, expiry date 8th October 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 29th April 2021, the patient received the 2nd dose of Shingrix. On 29th April 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional information was provided as follows:  The patient received 1st dose of Shingrix on 12 March 2021. The nurse reported that the patient received 2nd dose of Shingrix, less than recommended interval, which led to shortening of vaccination schedule. The reporter did not consent to follow up.
Patient feels arm, shoulder up to his neck stiff and the more he uses it the worse it gets. About a week after he got the shot since it did not get any better he got in touch with his PCP who suggested hot and cold compresses on the site. He kept doing it and massaging the area with no help. He also went to the doctor since nothing had helped about 3 weeks later, no pain, just feel his muscles all tightened up all the way to his neck. The PCP prescribed him an steroid pills. He took them but still no help. PCP recommended seeing a neurologist. Caller believes it is related to the shot, he takes it every year and never had this problem before. Still feel stiffness. Have not gone to neurologist, financial burden.
Around 7-21-16 pt. noticed hard red bumps on face (forehead area, nose, cheeks, around lips, inside ears) that itched & burned. On presentation today, looks as if scabs are healing. Has taken BENADRYL daily since 7-21-16.